Cases 21 - 30 of 1,455
UCB, Inc. et al v. Prinston Pharmaceutical Inc. et al
as 1:2024cv00167
Plaintiff:
UCB, Inc. and UCB Biopharma SRL
Defendant:
Prinston Pharmaceutical Inc. and Zhejiang Huahai Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al
as 1:2024cv00152
Plaintiff:
AbbVie Inc.
Defendant:
Prinston Pharmaceutical Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Lupin Limited et al
as 1:2024cv00138
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
McKesson Corporation v. Yiling Pharmaceutical, Inc.
as 1:2024cv00118
Plaintiff:
McKesson Corporation
Defendant:
Yiling Pharmaceutical, Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Breach of Contract
Eagle Pharmaceuticals, Inc. v. Apotex Inc. et al
as 1:2024cv00064
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Baxter Healthcare Corporation
as 1:2024cv00066
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Baxter Healthcare Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
as 1:2024cv00065
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Slayback Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2024cv00043
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2024cv00018
Plaintiff:
Vanda Pharmaceuticals Inc.
Defendant:
Teva Pharmaceuticals U.S.A., Inc.
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
